RU2018143564A - Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа - Google Patents

Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа Download PDF

Info

Publication number
RU2018143564A
RU2018143564A RU2018143564A RU2018143564A RU2018143564A RU 2018143564 A RU2018143564 A RU 2018143564A RU 2018143564 A RU2018143564 A RU 2018143564A RU 2018143564 A RU2018143564 A RU 2018143564A RU 2018143564 A RU2018143564 A RU 2018143564A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
carboxylic acid
use according
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
RU2018143564A
Other languages
English (en)
Russian (ru)
Other versions
RU2018143564A3 (enExample
Inventor
Беттина ЭРНСТ
Original Assignee
Пропонент Байотек Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пропонент Байотек Гмбх filed Critical Пропонент Байотек Гмбх
Publication of RU2018143564A publication Critical patent/RU2018143564A/ru
Publication of RU2018143564A3 publication Critical patent/RU2018143564A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2018143564A 2016-05-17 2017-05-17 Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа RU2018143564A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16169882.4 2016-05-17
EP16169882 2016-05-17
PCT/EP2017/061832 WO2017198702A1 (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion

Publications (2)

Publication Number Publication Date
RU2018143564A true RU2018143564A (ru) 2020-06-17
RU2018143564A3 RU2018143564A3 (enExample) 2020-07-23

Family

ID=56014856

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018143564A RU2018143564A (ru) 2016-05-17 2017-05-17 Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа

Country Status (13)

Country Link
US (1) US20200000751A1 (enExample)
EP (1) EP3458043A1 (enExample)
JP (1) JP6975473B2 (enExample)
KR (1) KR102430892B1 (enExample)
CN (1) CN109152754A (enExample)
AU (1) AU2017266726A1 (enExample)
BR (1) BR112018072177A2 (enExample)
CA (1) CA3020485A1 (enExample)
CL (1) CL2018003270A1 (enExample)
MX (1) MX2018013475A (enExample)
RU (1) RU2018143564A (enExample)
SG (2) SG11201808322PA (enExample)
WO (1) WO2017198702A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11948678B2 (en) * 2009-10-14 2024-04-02 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images
US11206245B2 (en) * 2009-10-14 2021-12-21 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images
GB202004690D0 (en) * 2020-03-31 2020-05-13 Edinburgh Napier Univ Composition for enhancing immune response of cells
US12414928B2 (en) 2021-05-14 2025-09-16 Rene Dumalaog Javier Viral inactivation spray and gargling formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063363A (en) * 1997-05-27 2000-05-16 Goodwin; Gary J Treatment for upper respiratory tract infections with potassium salts
HUP0101369A3 (en) * 1997-12-23 2002-11-28 Schering Corp Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
KR20060076775A (ko) * 2003-09-19 2006-07-04 오츠카 세이야쿠 가부시키가이샤 인간 β-디펜신 분비 촉진제
US20070256812A1 (en) * 2006-04-19 2007-11-08 Wen-Chen Wei Multidirectional heat dissipating structure
US20070286812A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
EP2903608B1 (en) * 2012-10-03 2019-08-28 Proponent Biotech GmbH Pharmaceutical composition comprising propionic acid for use in the treatment of viral infections

Also Published As

Publication number Publication date
AU2017266726A1 (en) 2018-10-11
SG11201808322PA (en) 2018-10-30
KR20190009294A (ko) 2019-01-28
US20200000751A1 (en) 2020-01-02
KR102430892B1 (ko) 2022-08-09
JP2019516797A (ja) 2019-06-20
MX2018013475A (es) 2019-08-12
SG10202006016QA (en) 2020-07-29
CL2018003270A1 (es) 2019-02-22
CN109152754A (zh) 2019-01-04
EP3458043A1 (en) 2019-03-27
BR112018072177A2 (pt) 2019-02-12
WO2017198702A1 (en) 2017-11-23
CA3020485A1 (en) 2017-11-23
RU2018143564A3 (enExample) 2020-07-23
JP6975473B2 (ja) 2021-12-01

Similar Documents

Publication Publication Date Title
JP5643849B2 (ja) スプレー用ゲルタイプ皮膚・粘膜付着型製剤およびそれを用いた投与システム
US4466973A (en) Method of treating nasal and sinus congestion
AU2007298814B2 (en) Galenic form for the trans-mucosal delivery of active ingredients
RU2019100425A (ru) Новая доза и препаративная форма
JP6762931B2 (ja) 経鼻組成物と該経鼻組成物の使用方法の改善
JP2023507094A5 (enExample)
RU2007130700A (ru) Комбинация соединений метилксантина и стероидов для лечения хронических распираторных заболеваний
JP2013516482A5 (enExample)
JP2013541583A (ja) 組み合わせ組成物
JP2011503044A5 (enExample)
JP2011500781A5 (enExample)
JP2024501919A5 (enExample)
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
JP2019516797A5 (enExample)
JP2016505050A5 (enExample)
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
CN1436073A (zh) 通过口服二甲基砜治疗打鼾
ES2894330T3 (es) Acido acetilsalicílico para uso en el tratamiento de la influenza de moderada a grave
CA2506962A1 (en) Synergistic combination comprising roflumilast and formoterol
JP2006508994A5 (enExample)
RU2019102890A (ru) Фармацевтические композиции, содержащие флурбипрофен
AU2020369029B2 (en) Novel pediatric combination
WO2023144614A1 (en) Nasal compositions and methods thereof
JP2024520767A5 (enExample)
JP2023539847A5 (enExample)